Compare MBIN & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MBIN | TMDX |
|---|---|---|
| Founded | 1990 | 1998 |
| Country | United States | United States |
| Employees | 735 | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.5B |
| IPO Year | N/A | 2019 |
| Metric | MBIN | TMDX |
|---|---|---|
| Price | $54.87 | $75.11 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 9 |
| Target Price | $43.67 | ★ $148.22 |
| AVG Volume (30 Days) | 143.9K | ★ 778.5K |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.89% | N/A |
| EPS Growth | N/A | ★ 382.18 |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | ★ $605,494,000.00 |
| Revenue This Year | $31.76 | $24.25 |
| Revenue Next Year | $3.73 | $18.75 |
| P/E Ratio | ★ $12.29 | $378.73 |
| Revenue Growth | N/A | ★ 37.13 |
| 52 Week Low | $29.20 | $60.11 |
| 52 Week High | $56.87 | $156.00 |
| Indicator | MBIN | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 73.49 | 54.63 |
| Support Level | $45.39 | $64.87 |
| Resistance Level | N/A | $79.60 |
| Average True Range (ATR) | 1.76 | 3.07 |
| MACD | 0.79 | 0.48 |
| Stochastic Oscillator | 89.97 | 68.23 |
Merchants Bancorp is a United States-based bank holding company operating multiple lines of business focused on FHA multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. Its segments include Multi-family Mortgage Banking, which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing, which offers mortgage warehouse financing, commercial loans and deposit services; and the Banking segment, which generates maximum revenue and provides portfolio lending for multi-family and healthcare facility loans, residential mortgage banking, agricultural lending, SBA lending and community banking.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.